Viewing Study NCT07076095


Ignite Creation Date: 2025-12-24 @ 2:08 PM
Ignite Modification Date: 2026-01-31 @ 3:40 AM
Study NCT ID: NCT07076095
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-07-21
First Post: 2025-07-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II/III Study of IBB0979 in Combination With Topotecan Versus Topotecan in Relapsed Small Cell Lung Cancer
Sponsor: SUNHO(China)BioPharmaceutical CO., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Small Cell Lung Cancer View
Keywords: